Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
World Journal of Surgery|September 26, 2002
Predictors of successful hepatic resection: prognostic usefulness of hepatic asialoglycoprotein receptor analysisNorihiro Kokudo, David R Vera, Keiichiro Tada, et al.
World Journal of Surgery|February 28, 2003
Hepatic resection for colorectal metastasis with macroscopic tumor thrombus in the portal veinKeiichiro Tada, Norihiro Kokudo, Makoto Seki, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 30, 2004
Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancerTaira Kinoshita, Atsushi Nashimoto, Yoshitaka Yamamura, et al.
The New England Journal of Medicine|November 6, 2007
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidineShinichi Sakuramoto, Mitsuru Sasako, Toshiharu Yamaguchi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 14, 2017
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06)Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 23, 2017
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 11, 2014
Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancerYusuke Horiuchi, Junko Fujisaki, Noriko Yamamoto, et al.
Targeted Oncology|June 17, 2016
Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05)Akihito Tsuji, Yu Sunakawa, Wataru Ichikawa, et al.
Clinical Colorectal Cancer|November 19, 2016
Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 TrialsYu Sunakawa, Wataru Ichikawa, Akihito Tsuji, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 20, 2015
Exploratory phase II trial in a multicenter setting to evaluate the clinical value of a chemosensitivity test in patients with gastric cancer (JACCRO-GC 04, Kubota memorial trial)Nobuhiko Tanigawa, Hiroki Yamaue, Shigekazu Ohyama, et al.
Pageof 4